Clinical Trial

Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients

Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to compare the efficacy of oral melatonin versus nebulized dexmedetomidine in attenuating the hemodynamic response to direct laryngoscopy and endotracheal intubation in controlled hypertensive patients prepared for general anesthesia
Trial Details
NCT Number NCT06935292
Lead Sponsor Tanta University
Conditions Tracheal Intubation Morbidity, Laryngoscopy, Hemodynamic Response
Enrollment 70 participants
Start Date 2025-04
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-20